GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly emerging as a major focus in therapeutic studies, largely due to its remarkable impact on controlling conditions such as second type diabetes and weight gain. Recent trials have shown that beyond glucose regulation, GLP-1 drug… Read More